Planned single, pivotal Phase 2/3 clinical trial, if positive, acceptable for Biological License Application (BLA) submission for Alzheimer’s ...
December 2024, immediately following the approval of the world's first mesenchymal stromal cells clinical trial, the U.S. FDA ...
Scientists have uncovered a hidden driver of ovarian cancer—high-risk mesenchymal stem cells lurking in the fallopian tubes.
AZoLifeSciences on MSN2h
Can Tissue Engineering and Regenerative Medicine Reverse Spinal Cord Injuries?Advances in tissue engineering offer hope for spinal cord injury repair, utilizing biomaterials, stem cells, and bioactive ...
News-Medical.Net on MSN5d
Pitt study uncovers a novel trigger of deadly form of ovarian cancerResearchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of ...
In the experiment, cells from the dental pulp of mice were exposed to a cytokine called tumor necrosis factor alpha (TNF-α), ...
Researchers at the University of Pittsburgh have identified a novel trigger for a deadly form of ovarian cancer: a subset of ...
A transformative study has uncovered the pivotal role of the protein Naked cuticle homolog 2 (NKD2) in regulating the differentiation of bone-forming osteoblasts and bone-resorbing osteoclasts.
ENCell inks an MOU with CRC to enhance collaboration in the field of cell and gene therapy (CGT), thus expanding its market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback